Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway.
Kumar S, Nandi A, Singh S, Regulapati R, Li N, Tobias JW, Siebel CW, Blanco MA, Klein-Szanto AJ, Lengner C, Welm AL, Kang Y, Chakrabarti R.
Kumar S, et al. Among authors: kang y.
Nat Commun. 2021 Jan 18;12(1):432. doi: 10.1038/s41467-020-20664-5.
Nat Commun. 2021.
PMID: 33462238
Free PMC article.